SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-089704
Filing Date
2024-08-14
Accepted
2024-08-14 16:47:43
Documents
15
Period of Report
2024-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421372d1_8k.htm   iXBRL 8-K 25043
2 EXHIBIT 99.1 tm2421372d1_ex99-1.htm EX-99.1 113925
6 GRAPHIC tm2421372d1_ex99-1img001.jpg GRAPHIC 6321
  Complete submission text file 0001104659-24-089704.txt   335214

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20240814.xsd EX-101.SCH 3018
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20240814_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20240814_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2421372d1_8k_htm.xml XML 3808
Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 241209037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)